2016
DOI: 10.2131/jts.41.143
|View full text |Cite
|
Sign up to set email alerts
|

Effect of penicillin-based antibiotics, amoxicillin, ampicillin, and piperacillin, on drug-metabolizing activities of human hepatic cytochromes P450

Abstract: -The effects of three kinds of penicillin-based antibiotics, amoxicillin, ampicillin, and piperacillin, on drug-metabolizing activity of human hepatic cytochrome P450 (P450 or CYP) were investigated. Metabolic activities of P450s expressed in recombinant Escherichia coli at substrate concentrations around the Michaelis constant were compared in the presence or absence of the antibiotics. Amoxicillin, ampicillin, and piperacillin at 0.5 or 1 mM concentrations neither inhibited nor stimulated CYP2C9-mediated tol… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
14
0

Year Published

2016
2016
2024
2024

Publication Types

Select...
10

Relationship

2
8

Authors

Journals

citations
Cited by 25 publications
(14 citation statements)
references
References 14 publications
0
14
0
Order By: Relevance
“…For example, azithromycin has a negligible effect on CYP3A4 (i.e., it does not inhibit CYP3A4 or increase blood concentrations of CYP3A4-metabolized statins) and could be given to patients receiving CDK4/6 inhibitors in place of clarithromycin [31] (Table 3). Finally, it should be noted that breast cancer patients treated with CDK4/6 inhibitors have a very low risk to develop febrile neutropenia and, anti-pseudomonas βlactam agents, i.e., drugs proven not interacting with CYP3A4-metabolized substrates [34], are the first choice treatment for high-risk patients who require hospitalization for intravenous antibiotic therapy [32], in those uncommon cases of febrile neutropenia and risk of septic shock.…”
Section: Cyp3a4-based Ddismentioning
confidence: 99%
“…For example, azithromycin has a negligible effect on CYP3A4 (i.e., it does not inhibit CYP3A4 or increase blood concentrations of CYP3A4-metabolized statins) and could be given to patients receiving CDK4/6 inhibitors in place of clarithromycin [31] (Table 3). Finally, it should be noted that breast cancer patients treated with CDK4/6 inhibitors have a very low risk to develop febrile neutropenia and, anti-pseudomonas βlactam agents, i.e., drugs proven not interacting with CYP3A4-metabolized substrates [34], are the first choice treatment for high-risk patients who require hospitalization for intravenous antibiotic therapy [32], in those uncommon cases of febrile neutropenia and risk of septic shock.…”
Section: Cyp3a4-based Ddismentioning
confidence: 99%
“…Although both chronic alcohol consumption and amoxicillin + clavulanic acid therapy have been reported to exert liver injury, information about their CYP2C9 inhibitory potential is hardly available. In contrast to amlodipine and tamoxifen that have the capability to inhibit CYP2C9 function, chronic alcohol consumption and amoxicillin + clavulanic acid therapy evoking liver injury were likely to have non-specific impact on CYP enzyme function rather than direct CYP2C9 inhibitory properties 66 , 67 .…”
Section: Discussionmentioning
confidence: 99%
“…Hence, the bacterial cell wall synthesis will be interrupted. The bacterial cell wall will be weakened leading to cell lysis [51]. This result suggests imipenem as the most efficient antibiotics against pathogens isolated from braised products sold in the city of Bangangte.…”
Section: Antibiotic Resistance Profile Of Strains Isolated From Braised Products Sold the City Of Bangangtementioning
confidence: 99%